By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eleven Biotherapeutics 



Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Eleven Biotherapeutics (EBIO) Announces Top-Line Results From Pivotal Phase 3 Study Of EBI-005 In Patients With Moderate To Severe Dry Eye Disease 5/18/2015 6:15:46 AM
Eleven Biotherapeutics (EBIO) Stock Nosedives 80% Premarket as Eye Drug Flunks Phase III Test 5/18/2015 6:14:51 AM
Eleven Biotherapeutics (EBIO) Presents Clinical Data On EBI-005 For The Treatment Of Dry Eye Disease And Allergic Conjunctivitis At Association for Research in Vision & Ophthalmology 2015 Annual Meeting 5/8/2015 10:17:38 AM
Eleven Biotherapeutics (EBIO) Presents Data On EBI-031 For The Treatment Of Diabetic Macular Edema At Association for Research in Vision & Ophthalmology 2015 Annual Meeting 5/6/2015 9:57:07 AM
Eleven Biotherapeutics (EBIO) Reports First Quarter 2015 Financial Results 4/30/2015 12:40:33 PM
Eleven Biotherapeutics (EBIO) Publishes Clinical Data On EBI-005 For The Treatment Of Allergic Conjunctivitis 4/29/2015 8:19:32 AM
Eleven Biotherapeutics (EBIO) To Present Data On Ocular Therapeutics Pipeline At The Association for Research in Vision & Ophthalmology 2015 Annual Meeting 4/22/2015 9:02:38 AM
Eleven Biotherapeutics (EBIO) To Report First Quarter 2015 Financial Results On April 30, 2015 4/21/2015 11:04:09 AM
Eleven Biotherapeutics (EBIO) Presents Phase 2 Clinical Data On EBI-005 For The Treatment Of Allergic Conjunctivitis At ASCRS 2015 Annual Meeting 4/16/2015 1:22:22 PM
Eleven Biotherapeutics (EBIO) Reports Fourth Quarter And Year-End 2014 Financial Results 3/4/2015 11:23:19 AM
1234567
//-->